Central Laboratory;
Naval General Hospital;
Beijing 100037;
Institute of Surgical Urology;
The First Hospital;
Peking University;
Beijing 100034;
Central Laboratory;
Naval General Hospital;
Beijing 100037;
Institute of Surgical Urology;
The First Hospital;
Peking University;
Beijing 100034;
Chimeric; antibody; Bladder; cancer; Eukaryotic; expression;